Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Issuance of Common Stock

Ampio Pharmaceuticals Issuance of Common Stock Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Issuance of Common Stock from 2009 to 2018.
  • Ampio Pharmaceuticals Issuance of Common Stock for the quarter ending September 09, 2018 was $8m a -17.79% decrease of -1m year over year
  • Ampio Pharmaceuticals Issuance of Common Stock for the last 12 months ending September 09, 2018 was $21m a 23.69% increase of 5m year over year
  • Ampio Pharmaceuticals Annual Issuance of Common Stock for 2017 was $16m a 75.83% increase of 12m from 2016
  • Ampio Pharmaceuticals Annual Issuance of Common Stock for 2016 was $4m a 99.26% increase of 4m from 2015
  • Ampio Pharmaceuticals Annual Issuance of Common Stock for 2015 was $0m a -237,846.19% decrease of -68m from 2014
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Issuance of Common Stock Data

09/2018$8m
06/2018$0m
03/2018$3m
12/2017$10m
06/2017$7m
09/2016$4m
12/2015$0m
03/2014$68m
12/2013$0m
09/2013$25m

Annual AMPE Issuance of Common Stock Data

2017$16m
2016$4m
2015$0m
2014$68m
2013$26m
2012$18m
2011$22m
2010$1m
2009$0m